
PauseRX Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: all-in compounded GLP-1 pricing with no membership and a named pharmacy and physician network
PauseRX scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on PauseRX’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
PauseRX is a cash-pay telehealth platform covering weight care, hormones, testosterone, sexual health and longevity. Compounded semaglutide starts at $199/mo and compounded tirzepatide at $249/mo, with provider review, medication, supplies and shipping included and no membership fee. Brand Wegovy, Zepbound and Foundayo are a $149 consultation, with medication billed separately by the manufacturer pharmacy. It names its pharmacy (Rush Pharmacy) and physician network (Beluga Health).
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to PauseRX
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
PauseRX at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Zepbound
- Starting price
- $199/mo (starting dose)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored PauseRX
Each dimension is scored algorithmically from PauseRX’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.3/10At $199/mo (starting dose), PauseRX runs about 11% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
7.6/10PauseRX offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.9/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
6.8/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.6/10PauseRX's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.4/10PauseRX provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this PauseRX review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$249/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with PauseRX
We walked PauseRX’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick a care area or treatment page (or use the 60-second Find My Care symptom picker).
- 2Review the plan price and what's included on the product page.
- 3Click Start My Visit, which opens the intake site.
- 4The first intake screen asks for your email to check for an existing account.
- Starting prices are shown before intake: compounded semaglutide from $199/mo, tirzepatide from $249/mo, brand consultation $149.
- Only starting prices are published; there is no per-dose price list.
- Says a provider reviews your intake within 24 hours, and you're not charged for treatment if it isn't appropriate.
- Billed when medication ships, with a monthly renewal notice; orders can't be changed once submitted.
- Photo ID and selfie are required, and some states require a live video visit or chat.
- Microdose plan shows '$249/mo' on one page and 'Price coming' on another.
PauseRX customer support
- Phone
- (844) 917-2873
- hello@pauserx.com
GLP-1 medications PauseRX offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
From $199/mo with provider review, medication, supplies and shipping included. No membership fee. 30- or 90-day supply options; per-dose prices not published.
From $249/mo all-in (review, medication, supplies, cold-packed shipping). A lower-dose GLP-1/GIP + B12 microdose plan is also listed from $249/mo.
Ready to get started?
Plans and promotions change often, so check PauseRX's current pricing and active discounts before you decide.
What we like
- Names its pharmacy (Rush Pharmacy) and physician network (Beluga Health) in its FAQ
- Compounded pricing is all-in: provider review, medication, supplies and shipping in one monthly price
- No membership fee, and you can skip a month or cancel anytime
- Billed when your medication ships, with a renewal notice each month rather than a silent auto-charge
- Not charged for treatment if the provider decides it isn't right for you
- Brand Wegovy, Zepbound and Foundayo available through a $149 consultation
- Named founder (Jessica Lynne White, PT) and a LegitScript Certified seal on the site
- Broad menu beyond weight care: hormones, testosterone, sexual health, labs and recovery
Watch-outs
- Only 'from' prices are published for compounded GLP-1s, with no per-dose price list
- Brand-name route is a $149 consult only; the medication cost is billed separately by the manufacturer pharmacy
- Once an order is submitted it can't be changed or canceled, and shipped medications can't be returned
- No states-served list; the FAQ just says 'nationwide service'
- No named medical director; prescribing runs through Beluga Health's network
- Insurance not accepted for compounded care
- Some states require a live video visit or chat, and a photo ID plus selfie is required
- Microdose plan is listed as both '$249/mo' and 'Price coming' on different pages
PauseRX: a compounded GLP-1 platform that tells you who's behind it
Most direct-to-consumer GLP-1 sites hide the machinery: they take your money, ship you a vial, and never name the pharmacy that filled it. PauseRX is built differently, and that's the main reason to consider it. Its FAQ names the pharmacy that compounds your medication (Rush Pharmacy, a 503A pharmacy in Oviedo, Florida). It also names the clinical network that handles prescribing (Beluga Health) and a founder, Jessica Lynne White, PT. That level of disclosure is uncommon for a cash-pay prescription site.
PauseRX has also grown well past weight loss, and it now covers hormones, including perimenopause and menopause care, plus testosterone, sexual health, labs and recovery. Weight care built around compounded semaglutide and tirzepatide is still the core offer.
How the pricing works
Compounded semaglutide starts at $199 a month (starting dose), and compounded tirzepatide starts at $249. Both are "from" prices, and PauseRX doesn't publish a per-dose list, so your bill may change as your provider adjusts the dose. Ask for your exact monthly cost first.
For context, $199 (starting dose) sits a bit above the category median of $179, so this isn't the cheapest compounded option. The upside is that the price is all-in: provider review, medication, supplies and shipping come in one monthly figure, with no membership fee. A lower-dose tirzepatide plus B12 microdose plan is also listed from $249, though another page on the site still says its price is coming.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
Check three billing details before you start an intake:
- You're billed when your medication ships, not when you order, and you get a renewal notice each month instead of a silent auto-charge.
- There's no membership: PauseRX says you can skip a month or cancel anytime, and you can choose a 30- or 90-day supply.
- A submitted order is locked: it can't be changed or canceled once it's in, and shipped prescriptions are final sale, though lost or damaged packages are reshipped.
What you get, and how it's dispensed
The plan bundles the medication and the provider review, so you don't pay a separate visit fee. PauseRX says a provider reviews your intake within 24 hours, and if treatment isn't right for you, you aren't charged for it. Visits are mostly asynchronous, but some states require a live video visit or secure chat, and everyone uploads a photo ID and a selfie.
Brand-name Wegovy (pen or pill), Zepbound and Foundayo are offered through a $149 provider consultation. If you're prescribed one, the medication is filled and billed separately by NovoCare or LillyDirect. So PauseRX handles the prescribing, and the drug cost goes to the manufacturer pharmacy. That's a workable route, but the full monthly cost isn't shown on PauseRX's own pages.
The transparency story, and the gaps
Because PauseRX names Rush Pharmacy and Beluga Health, you can look up both yourself instead of taking a faceless website's word for it. Quality varies between compounding operators, so being able to check the pharmacy is a safety advantage. The site also shows a LegitScript Certified seal that links to LegitScript's own checker.
Several things are still missing:
- No state-by-state coverage list: the FAQ says "nationwide service" but doesn't list states, so contact support if you're unsure.
- No named medical director: Beluga Health runs prescribing, but no individual physician is named as the program's lead.
- Starting prices only: there's no published price for higher doses or for the 90-day supply.
- Cash-pay only: insurance isn't accepted for compounded care, so plan to pay the full price yourself.
Who should choose PauseRX, and who should skip it
Choose it if you want a compounded GLP-1 program from a company willing to show its work: named pharmacy, named clinical network and a named founder. All-in pricing, no membership and billing at ship time are friendly to your budget. If openness ranks above rock-bottom price, PauseRX is a reasonable candidate.
Skip it if you need insurance, or if you want to know your exact cost at every dose before you start. Brand-name buyers should budget for the manufacturer's price on top of the $149 consult. And since a submitted order can't be canceled, review each refill notice before it goes through. Arc-1 skips subscriptions entirely, selling each dose as a one-off purchase, though its prices rise with dose.
Bottom line
PauseRX is a well-disclosed, mid-priced compounded GLP-1 platform that is open about its supply chain, with Rush Pharmacy, Beluga Health and a named founder all on the record. What holds it back is the missing state list, the lack of a named medical director, and starting prices with no dose ladder. Pin down your exact price and state eligibility before you sign up, and read more about how we weigh these factors in our scoring methodology.
The Bottom Line
PauseRX scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with PauseRX?
From $199/mo (starting dose). See current pricing and start your free consultation.
PauseRX might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare PauseRX vs…
PauseRX scores6.6/10
Side-by-side pricing, medications and scores. Pick a matchup.
PauseRX vs Amazon One Medical
Amazon One Medical scores 8.5/10

PauseRX vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this PauseRX review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See PauseRX's current pricing
Plans from $199/mo (starting dose). Start your free consultation to check eligibility and today's price.